跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ POSACONAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ POSACONAZOLE
Authorized
STANDARD
SANDOZ POSACONAZOLE
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
647fa182db17b411
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
647fa182db17b411
Drug Approval Canada Name
SANDOZ POSACONAZOLE
Product Name
SANDOZ POSACONAZOLE
Status
Marketed
Status Date
2020-12-08
Original Market Date
2020-12-08
Din
02496259
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:14.08
Atc Original
J02AC04 POSACONAZOLE
Atc Name
j 02 ac 04
Aig Number
0152201002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
POSACONAZOLE
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
647fa182db17b411
Type
Standard
Back to Health Canada Approvals